A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer
The primary objective of this study is to find out the response rate of twice weekly
paclitaxel and cisplatin and weekly HDFL in recurrent or metastatic esophageal carcinoma
patients who need palliative Chemotherapy. The secondary objectives include overall
survival, progression-free survival, and toxicity.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Ann-Lii Cheng, M.D., Ph.D.
Department of Oncology, National Taiwan University hospital
Taiwan: Department of Health